Biotech industry failed by UK, says UCB
February 27, 2014Research and Development, Sales and Marketing Cimzia, NHS, UCB, biotech, doliveux, tellier, vimpat
The UK biotechnology industry has ‘missed the boat’ and not fulfilled its potential, according to outgoing UCB chief executive Roch …
Best of Health Awards judges appointed
February 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Best of Health, IPA, henderson
The 2014 IPA Best of Health Awards which highlight the top creative advertising agencies in the industry has named the …
Mid Staffs to be ‘dissolved’
February 27, 2014Sales and Marketing Hunt, Mid Staffs, NHS, NHS England, tsas
The scandal-hit Mid Staffordshire NHS Foundation Trust is to be dissolved, after health secretary Jeremy Hunt accepted the recommendation of …
InterMune scores in lung trial
February 26, 2014Research and Development, Sales and Marketing Esbriet, FDA, IPF, InterMune, fvc, lung
InterMune has taken another step on its lengthy road to get the US regulator to approve its drug Esbriet for …
BMS/AZ fat disorder drug gains FDA approval
February 26, 2014Research and Development, Sales and Marketing AstraZeneca, BMS, FDA, hep C, metreleptin, myalept
Bristol-Myers Squibb and partner AstraZeneca have been granted FDA approval for a new drug to treat rare and potentially fatal …
Bupa hires MHP Health head
February 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BUPA, gowrley, mhp health
Rupert Gowrley is leaving his role as joint head at MHP Health in order to start with Bupa as its …
Lilly’s diabetes drug matches Victoza
February 26, 2014Research and Development, Sales and Marketing EMA, FDA, Victoza, dulaglutide, lilly
Eli Lilly’s once-weekly diabetes candidate dulaglutide has matched Novo Nordisk’s established once-daily Victoza (liraglutide) when it comes to lowering blood …
FDA: India needs more inspectors
February 25, 2014Manufacturing and Production FDA, India, generics, hamburg
The Food and Drug Administration is to put more inspectors on the ground in India, following a visit there by …
Samsung focussing increasingly on health tech
February 25, 2014Medical Communications, Sales and Marketing Apple, Samsung, digital, health tech, innovation lab, smartwatch
Samsung has partnered with a US university to create a digital health innovation laboratory whilst also unveiling some new health-tracking …
UCB names next chief executive
February 25, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, tellier
Biopharma firm UCB has confirmed its current chief executive Roch Doliveux is to be replaced by Jean-Christophe Tellier. Tellier (pictured) …
NICE restricts Yervoy use
February 25, 2014Sales and Marketing BMS, Cancer, NHS, NICE, Yervoy, melanoma
Bristol-Myers Squibb has been dealt a blow by NICE after the UK cost watchdog recommended that the use of skin …
FDA given $20 million for generic testing
February 24, 2014Manufacturing and Production, Sales and Marketing ADHD, FDA, generics, hamburg
The FDA has been given $20 million to help it assess generic treatments, a group of drugs that makes up …
Europe poised for generic Symbicort
February 24, 2014Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics
The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …
CHMP breathes new life into GSK, Teva and Novartis
February 24, 2014Research and Development, Sales and Marketing CHMP, COPD, EMA, GSK, Gilead, Teva, asthma, onoro
The CHMP has given its backing to a number of new treatments for respiratory diseases, which include two from London-based …
A treatment room view
February 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, Roche, avastin, hinsely
A little more than a year ago, Lisa Hinsley’s prospects were not good. The mother of three had been diagnosed …
New VP of Operations for Exco InTouch
February 24, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exco InTouch, burke
Healthcare data services firm Exco InTouch has appointed Laurence Burke as its vice president of Operations. Burke takes over 20 …
‘Compassionate’ use of hep C combo
February 24, 2014Research and Development, Sales and Marketing CHMP, EMA, Gilead, hep C, ledipasvir, sovaldi
A key adviser to the European regulator has said that Gilead Sciences’ fixed-dose combination of Sovaldi and ledipasvir can be …
New head of Biosimilars for Merck KGaA
February 21, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, biosimilars, simon sturge
Simon Sturge is joining Merck KGaA from Boehringer Ingelheim in order to head its Biosimilars unit. In his new role …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
